Development and characterisation of a new model of rat trophoblasts

Toxicology in Vitro

Volumn 23, Issue 1, 2009, Pages 141-147

  Beghin, D ^a,b   Delongeas, J L ^b   Claude, N ^b   Forestier, F ^a   Farinotti, R ^a,c   Gil, S ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bcrp; P Glycoprotein; Placenta; Primoculture and cryopreserved trophoblasts; Rat

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CYCLOSPORIN A; ELACRIDAR; GLYCOPROTEIN P; VALSPODAR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; IN VITRO STUDY; INNER EAR; NONHUMAN; PLACENTA; PLACENTAL TRANSFER; PREGNANCY; PROTEIN EXPRESSION; RAT; STATISTICAL MODEL; TROPHOBLAST; WESTERN BLOTTING;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL PROLIFERATION; CELL SURVIVAL; CRYOPRESERVATION; CYCLOSPORINE; CYCLOSPORINS; DRUG EVALUATION, PRECLINICAL; FEMALE; FLUORESCEINS; FLUORESCENT DYES; NEOPLASM PROTEINS; ORGAN CULTURE TECHNIQUES; P-GLYCOPROTEIN; PREGNANCY; RATS; RATS, WISTAR; RHODAMINE 123; TROPHOBLASTS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 58149295513     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.10.007     Document Type: Article

References (34)

1. Carter A.M. Evolution of the placenta and fetal membranes seen in the light of molecular phylogenetics. Placenta 22 (2001) 800-807
2. Carter A.M., Tanswell B., Thompson K., and Han V.K. Immunohistochemical identification of epithelial and mesenchymal cell types in the chorioallantoic and yolk sac placentae of the guinea-pig. Placenta 19 (1998) 489-500
3. Cygalova L., Ceckova M., Pavek P., and Staud F. Role of breast cancer resistance protein (Bcrp/ABCG2) in fetal protection during gestation in rat. Toxicol. Lett. 178 (2008) 176-180
4. Essodaigui M., Broxterman H.J., and Garnier-Suillerot A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37 (1998) 2243-2250
5. Georgiades P., Ferguson-Smith A.C., and Burton G.J. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23 (2002) 3-19
6. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., and Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268 (1993) 21493-21496
7. Jayanthi L.D., Vargas G., and DeFelice L.J. Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts. Br. J. Pharmacol. 135 (2002) 1927-1934
8. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., and Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92 (2000) 1651-1656
9. Kitano T., Iizasa H., Terasaki T., Asashima T., Matsunaga N., Utoguchi N., Watanabe Y., Obinata M., Ueda M., and Nakashima E. Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J. Cell Physiol. 193 (2002) 208-218
10. Kliman H.J., Nestler J.E., Sermasi E., Sanger J.M., and Strauss J.F. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118 (1986) 1567-1582
11. Knipp G.T., Audus K.L., and Soares M.J. Nutrient transport across the placenta. Adv. Drug Deliver. Rev. 38 (1999) 41-58
12. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., and Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12 (1998) 457-463
13. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv. Drug Deliver. Rev. 55 (2003) 53-81
14. MacFarland A., Abramovich D.R., Ewen S.W., and Pearson C.K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem. J. 26 (1994) 417-423
15. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., and Schellens J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer res. 61 (2001) 3458-3464
16. Mao Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm. Res. 25 (2008) 1244-1255
17. Marin J.J., Briz O., and Serrano M.A. A review on the molecular mechanisms involved in the placental barrier for drugs. Curr. Drug Deliver. 1 (2004) 275-289
18. Mitra P.A. Multidrug resistance mechanisms and in vitro models of the placental barrier, in preclinical biopharmaceutics. In: Ehrhardt C.K., and Kim K.-J. (Eds). In Situ, In Vitro, and In Silico Tools for Drug Absorption Studies (2008), Springer, New York 368-396
19. Novotna M., Libra A., Kopecky M., Pavek P., Fendrich Z., Semecky V., and Staud F. P-glycoprotein expression and distribution in the rat placenta during pregnancy. Reprod. Toxicol. 18 (2004) 785-792
20. Pascolo L., Fernetti C., Pirulli D., Crovella S., Amoroso A., and Tiribelli C. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem. Biophys. Res. Commun. 303 (2003) 259-265
21. Pavek P., Fendrich Z., Staud F., Malakova J., Brozmanova H., Laznicek M., Semecky V., Grundmann M., and Palicka V. Influence of P-glycoprotein on the transplacental passage of cyclosporine. J. Pharm. Sci. 90 (2001) 1583-1592
22. Pavek P., Staud F., Fendrich Z., Sklenarova H., Libra A., Novotna M., Kopecky M., Nobilis M., and Semecky V. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J. Pharmacol. Exp. Ther. 305 (2003) 1239-1250
23. Rapaka R.S., and Porreca F. Development of delta opioid peptides as nonaddicting analgesics. Pharmacol. Res. 8 (1991) 1-8
24. Robey R.W., Steadman K., Polgar O., Morisaki K., Blayney M., Mistry P., and Bates S.E. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res. 64 (2004) 1242-1246
25. Sahgal N., Canham L.N., Canham B., and Soares M.J. Rcho-1 trophoblast stem cells: a model system for studying trophoblast cell differentiation. Methods Mol. Med. 121 (2006) 159-178
26. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliver. Rev. 55 (2003) 3-29
27. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., and Schinkel A.H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104 (1999) 1441-1447
28. Soares M.J. Developmental changes in the intraplacental distribution of placental lactogen and alkaline phosphatase in the rat. J. Reprod. Fertil. 79 (1987) 93-98
29. Soares M.J., Schaberg K.D., Pinal C.S., De S.K., Bhatia P., and Andrews G.K. Establishment of a rat placental cell line expressing characteristics of extraembryonic membranes. Dev. Biol. 124 (1987) 134-144
30. Staud F., Vackova Z., Pospechova K., Pavek P., Ceckova M., Libra A., Cygalova L., Nachtigal P., and Fendrich Z. Expression and transport activity of breast cancer resistance protein (Bcrp/ABCG2) in dually perfused rat placenta and HRP-1 cell line. J. Pharmacol. Exp. Ther. 319 (2006) 53-62
31. St-Pierre M.V., Serrano M.A., Macias R.I., Dubs U., Hoechli M., Lauper U., Meier P.J., and Marin J.J. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R1495-1503
32. Young A.M., Allen C.E., and Audus K.L. Efflux transporters of the human placenta. Adv. Drug Deliver. Rev. 55 (2003) 125-132
33. Zhang Y., Wang H., Unadkat J.D., and Mao Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug. Metab. Dispos. 35 (2007) 2154-2158
34. Zhou L., Naraharisetti S.B., Wang H., Unadkat J.D., Hebert M.F., and Mao Q. The breast cancer resistance protein (Bcrp1/ABCG2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol. Pharmacol. 73 (2008) 949-959